Article Versions Notes

Zaki MSA, Eldeen MA, Abdulsahib WK, Shati AA, Alqahtani YA, Al-Qahtani SM, Otifi HM, Asiri A, Hassan HM, Emam Mohammed Ahmed H, et al. A Comprehensive Pan-Cancer Analysis Identifies CEP55 as a Potential Oncogene and Novel Therapeutic Target. Diagnostics. 2023; 13(9):1613. https://doi.org/10.3390/diagnostics13091613

Zaki, Mohamed Samir A., Muhammad Alaa Eldeen, Waleed K. Abdulsahib, Ayed A. Shati, Youssef A. Alqahtani, Saleh M. Al-Qahtani, Hassan M. Otifi, Ashwag Asiri, Hesham M. Hassan, Hebatallah Emam Mohammed Ahmed, and et al. 2023. "A Comprehensive Pan-Cancer Analysis Identifies CEP55 as a Potential Oncogene and Novel Therapeutic Target" Diagnostics 13, no. 9: 1613. https://doi.org/10.3390/diagnostics13091613

Zaki, M. S. A., Eldeen, M. A., Abdulsahib, W. K., Shati, A. A., Alqahtani, Y. A., Al-Qahtani, S. M., Otifi, H. M., Asiri, A., Hassan, H. M., Emam Mohammed Ahmed, H., Dawood, S. A., Negm, A., & Eid, R. A. (2023). A Comprehensive Pan-Cancer Analysis Identifies CEP55 as a Potential Oncogene and Novel Therapeutic Target. Diagnostics, 13(9), 1613. https://doi.org/10.3390/diagnostics13091613